Women's Health Ultrasound

Catch up on the top radiology content of the past week.

In comparison to initial sonographer assessment of echocardiograms, cardiologists are over 10 percent less likely to change initial artificial intelligence (AI) assessment of left ventricular ejection fraction (LVEF), according to new research recently presented at the European Society of Cardiology Congress in Barcelona, Spain.

Researchers found the combination of magnetic resonance imaging (MRI) and contrast-enhanced mammography was nearly 22 percent more effective at detecting breast lesions than MRI-directed ultrasound.

Catch up on the top radiology content of the past week.

Published by the American College of Cardiology, the expert recommendations offer insights on the role of intravascular ultrasound for diagnosing and treating peripheral vascular disease in the lower extremity.

Catch up on the top radiology content of the past week.

While the Ovarian-Adnexal Reporting and Data System ultrasound (O-RADS US) system provides a standardized and validated system for classification and risk stratification of ovarian and adnexal masses, a variety of clinical scenarios may prohibit or limit use of the system.

Catch up on the top radiology content of the past week.

The next-generation ultrasound system reportedly offers enhanced images through graphic-based beamforming technology, a variety of artificial intelligence (AI)-powered tools and reduced exam times.

Catch up on the top radiology content of the past week.

An updated machine learning model demonstrated a 23 percent improvement in accuracy and a 36.1 percent improvement in sensitivity over visual radiologist assessment of ultrasound images for differentiating malignant lymph nodes and benign COVID-19 vaccination-related changes to lymph nodes.

In recently issued statements, different radiology organizations have offered perspectives on the physician-patient relationship and the potential impact of the Supreme Court’s decision to overturn Roe v. Wade.

The review of breast cancer screening guidelines from the United States and abroad summarized current recommendations on modalities, intervals, and screening age considerations.

In what may be the largest study to date to examine the use of whole-body imaging to assess multisystem thrombosis in patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, researchers found multiple sites of thrombosis in 83 percent of patients who had additional CT, MRI and/or ultrasound imaging beyond the area of their primary complaint.

While COVID-19 vaccine clinical trials noted that post-vaccine axillary lymphadenopathy lasted for one to 10 days, emerging breast ultrasound research found a mean resolution of 127 days after a first vaccine dose.

Check out top radiology content from the past week.

The portable ATUSA™ System reportedly provides 3D ultrasound visualization of the entire breast volume in two minutes.

Review top radiology content from the week.

A new study suggests that deep learning algorithms with multimodal ultrasound have comparable specificity and sensitivity to subjective expert assessment and use of the O-RADS classification to distinguish between benign and malignant ovarian tumors.

What is your diagnosis?

Validating a prognostic scoring system for locoregional recurrence risk in post-mastectomy patients with varying levels of axillary lymph node involvement, emerging research suggests patients with intermediate risk for breast cancer recurrence could benefit from post-mastectomy radiotherapy.

Review top radiology content from the week.

Preliminary ultrasound findings from a study of over 3,000 women in early pregnancy found no association between fetal anomalies and initial COVID-19 vaccination.

Review top radiology content from the week.

Review top radiology content from the week.

Review top radiology content from the week.

The expanded FDA clearance for Collaboration Live (Philips) gives clinicians the option to consult on or diagnose ultrasound images from their mobile devices.

In combination with cloud-based data infrastructure and artificial intelligence (AI) applications, handheld ultrasound devices may have the potential to significantly enhance efficiency for providers and contribute to improved patient outcomes.

In addition to newly added advances with hemodynamic assessment and obstetric measurements, Lumify also offers a B-line quantification tool and AI-enhanced algorithms that may bolster ultrasound lung imaging in severe COVID-19 cases.

Emerging research suggests that mammograms should not be delayed for women who develop unilateral lymphadenopathy after receiving COVID-19 vaccines, and that follow-up imaging is unnecessary for patients who have no history of cancer or suspicious concurrent symptoms.